CLINICAL_TRIALS
trial_result
· 2026-04-09
Clinical Trial Update: Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) [Phase 3]
Summary
Phase 3 PROSERA trial evaluating Seralutinib for pulmonary arterial hypertension has completed. The update covers efficacy and safety in adult participants.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GB002, Inc. | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED